Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Spies

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Psychiatry|October 26, 2020
Effect of Ketamine on Limbic GABA and Glutamate: A Human <i>In Vivo</i> Multivoxel Magnetic Resonance Spectroscopy StudyLeo R Silberbauer, Benjamin Spurny, Patricia Handschuh, et al.
Translational Psychiatry|June 15, 2023
Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivoMarie Spies, Matej Murgaš, Chrysoula Vraka, et al.
The International Journal of Neuropsychopharmacology|December 27, 2022
Effect of MAOA DNA Methylation on Human in Vivo Protein Expression Measured by [11C]harmine Positron Emission TomographyPatricia A Handschuh, Matej Murgaš, Chrysoula Vraka, et al.
Frontiers in Human Neuroscience|February 22, 2017
Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major DepressionGregory M James, Pia Baldinger-Melich, Cecile Philippe, et al.
JAMA Psychiatry|October 23, 2014
The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomographyThomas Vanicek, Marie Spies, Christina Rami-Mark, et al.
British Journal of Clinical Pharmacology|October 21, 2024
Single-dose and steady-state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug-drug interaction studyAmelie Leutzendorff, Valentin Al Jalali, Martin Bauer, et al.
Journal of Psychiatry & Neuroscience : JPN|September 26, 2023
Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapyMelisande E Konadu, Murray B Reed, Ulrike Kaufmann, et al.
The International Journal of Neuropsychopharmacology|October 19, 2017
Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission TomographyMarie Spies, Gregory M James, Neydher Berroterán-Infante, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 18, 2016
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and geneticsAndrea Schmitt, Dan Rujescu, Micha Gawlik, et al.
Psychoneuroendocrinology|August 20, 2021
High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary reportGeorg S Kranz, Marie Spies, Chrysoula Vraka, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Psychiatry|October 26, 2020
Effect of Ketamine on Limbic GABA and Glutamate: A Human <i>In Vivo</i> Multivoxel Magnetic Resonance Spectroscopy StudyLeo R Silberbauer, Benjamin Spurny, Patricia Handschuh, et al.
Translational Psychiatry|June 15, 2023
Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivoMarie Spies, Matej Murgaš, Chrysoula Vraka, et al.
The International Journal of Neuropsychopharmacology|December 27, 2022
Effect of MAOA DNA Methylation on Human in Vivo Protein Expression Measured by [11C]harmine Positron Emission TomographyPatricia A Handschuh, Matej Murgaš, Chrysoula Vraka, et al.
Frontiers in Human Neuroscience|February 22, 2017
Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major DepressionGregory M James, Pia Baldinger-Melich, Cecile Philippe, et al.
JAMA Psychiatry|October 23, 2014
The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomographyThomas Vanicek, Marie Spies, Christina Rami-Mark, et al.
British Journal of Clinical Pharmacology|October 21, 2024
Single-dose and steady-state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug-drug interaction studyAmelie Leutzendorff, Valentin Al Jalali, Martin Bauer, et al.
Journal of Psychiatry & Neuroscience : JPN|September 26, 2023
Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapyMelisande E Konadu, Murray B Reed, Ulrike Kaufmann, et al.
The International Journal of Neuropsychopharmacology|October 19, 2017
Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission TomographyMarie Spies, Gregory M James, Neydher Berroterán-Infante, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 18, 2016
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and geneticsAndrea Schmitt, Dan Rujescu, Micha Gawlik, et al.
Psychoneuroendocrinology|August 20, 2021
High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary reportGeorg S Kranz, Marie Spies, Chrysoula Vraka, et al.
Pageof 5